Improve the functional correlation of TCR T cells by replacing affinity with avidity

Part of: TCR T cells

Improve the functional correlation of TCR T
cells by replacing affinity with avidity

This study aimed to screen a panel of affinity-tuned TCR T cells and find the most potent candidates.

T cells with high antigen-affinity TCRs are, in general, functionally superior to those with low antigen-affinity. However, upon breaching an optimum, T-cell functionality diminishes, and negative T-cell regulation increases. The researchers selected three TCR constructs based on their affinity to evaluate T-cell avidities upon interaction with a melanoma cell line (Figure 1).

NY-ESO-1 peptide pulsing on QMα and DMβ resulted in marked avidity enhancement compared with the non-pulsed conditions  (Figure 2).  In contrast to affinity measurements, the avidity data correlated with T-cell function, explaining the diminishing results observed among T cells with the highest affinities.

The reverse relationship between affinities and avidities of QMα and DMβ can explain reduced functionalities of high-affinity TCR T cells. This outcome suggests that avidity is a better predictor of TCR T-cell functionality compared with affinity.

1 Panel of TCR-transduced T cells based on their affinity. WT (baseline), DMβ (medium affinity), and QMα (high affinity) were selected for the experiment.

2 Avidity curves showing the proportion of bound TCR T cells to non-pulsed or peptide-pulsed Na8 melanoma cells at increasing acoustic forces. Each plot represents measurements performed on WT (left), DMβ (center), or QMα (right). (rForce indicates relative force.)

Data courtesy of Dr. Nathalie Rufer at the University of Lausanne
Read more:
Hebeisen et al. (2013) Front. Immunol.


z-Movi® High-throughput Label-free Cell Interaction Studies

The z-Movi® is a unique instrument that measures the avidity between immune cells and their targets, enabling you to identify the most potent immunotherapeutic effector cells. This new technology provides you with predictive, reproducible, and fast high-throughput results at a single-cell resolution without compromising cell viability. All within a compact little box that easily fits inside the flow hood for sterile and safe sample handling

    Download the brochure to learn more

    Would you like to receive exclusive news on the latest publications, events, and breakthrough science from the dynamic single-molecule and cell avidity analysis communities?
    Yes, pleaseNo, thank you

    You can unsubscribe at any time from our marketing emails. By submitting the form you agree to LUMICKS' privacy policy.

    Join our newsletter

    Join our newsletter

    Get exclusive news on the latest publications, product developments, events and breakthrough science.

    By agreeing to receive marketing communications, you subscribe to our newsletter. You can change your mind at any time by clicking the unsubscribe link in any marketing email you receive from us. By submitting the form you agree to LUMICKS' privacy policy.

    Download our webinar recording:


    Download our Cell Therapy (CAR-T, TCR, NK) applications deck